secwatch / observer

8-K filed March 6, 2025, 6:59 PM ET ticker SYRE CIK 0001636282

other material confidence high sentiment negative materiality 0.75

Spyre dismisses PwC as auditor, appoints KPMG; discloses material weakness in controls

Spyre Therapeutics, Inc.

PwC dismissed as auditor effective Feb 28, 2025; KPMG appointed as new independent auditor for FY2025.
No disagreements with PwC on accounting principles; material weakness identified as of Dec 31, 2024 in controls over EPS calculation for convertible preferred stock.
Material weakness led to restatement of FY2023 consolidated financial statements.
PwC's reports for FY2024 and FY2023 were unqualified.

item 4.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-048423
form_type: 8-K
ticker: SYRE
cik: 0001636282
company_name: Spyre Therapeutics, Inc.
filed_at: 2025-03-06T23:59:59+00:00
discovered_at: 2026-05-14T18:03:04.262050+00:00
generated_at: 2026-05-25T06:08:05.922583+00:00
sec_items: ["4.01", "9.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-048423
json_url: https://secwatch.observer/filing/0001193125-25-048423.json
markdown_url: https://secwatch.observer/filing/0001193125-25-048423.md
text_url: https://secwatch.observer/filing/0001193125-25-048423.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1636282/000119312525048423/0001193125-25-048423-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1636282/000119312525048423/d861533d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

Liberty Global names Stephen van Rooyen as Ziggo Group CEO; plans Amsterdam listing in 2027

Liberty Global Ltd. June 1, 2026, 4:07 PM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

IDYA

IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma

IDEAYA Biosciences, Inc. June 1, 2026, 4:05 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

FULC

Fulcrum Therapeutics discontinues pociredir program in SCD; initiates strategic review

Fulcrum Therapeutics, Inc. June 1, 2026, 4:05 PM ET other_material Items 8.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

MDAI

Spectral AI gets FDA clearance for DeepView burn indication; targets first commercial sales by year-end 2026

Spectral AI, Inc. June 1, 2026, 4:01 PM ET other_material Items 5.07, 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

PUBC

Purebase to receive 20% of net proceeds from CoreTer mining deal; waives corporate opportunities

Purebase Corp June 1, 2026, 3:42 PM ET other_material Items 1.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

BGS

B&G Foods provides College Inn/Kitchen Basics acquisition financials: FY2025 revenue $124.9M, op loss $0.8M

B&G Foods, Inc. June 1, 2026, 11:52 AM ET other_material Items 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

LIXT

Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC. June 1, 2026, 8:55 AM ET other_material Items 5.02, 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001193125-25-048423

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.